文献速递眼整形与眼眶

眼眶炎性疾病中IGF-1R与PPARγ信号通路的富集:迈向发病机制理解

Enrichment of IGF-1R and PPARγ signalling pathways in orbital inflammatory diseases: steps toward understanding pathogenesis.
PubMed 文献 · Br J Ophthalmol · 2021-02-26

该二次分析对83例受试者(25例TAO、6例眼眶GPA、7例眼眶结节病、25例NSOI、20例健康对照)的眶脂肪组织基因表达进行通路分析,发现OID患者IGF-1R下游(MAPK/RAS/RAF/MEK/ERK和PI3K/Akt/mTOR)、PPARγ、脂肪细胞因子和AMPK信号通路存在扰动,GPA、TAO、sarcoidosis和NSOI均显示这些通路的显著差异表达。

要点

  • OID各亚型(TAO、GPA、sarcoidosis、NSOI)共享IGF-1R、PPARγ、脂肪细胞因子和AMPK通路富集。
  • GPA样本中IGF-1R相关PI3K-Akt(p=0.001)、RAS(p=0.005)、PPARγ(p=0.002)、脂肪细胞因子(p=0.004)和AMPK(p<0.001)通路基因表达与对照差异显著。
  • TAO、sarcoidosis和NSOI样本在这些通路中也存在统计学显著差异基因表达。

核心结论

  • TAO、GPA、sarcoidosis和NSOI虽为异质性病理,但共享IGF-1R、PPARγ、脂肪细胞因子和AMPK信号通路的富集。
  • 基因表达通路分析提示,除TAO外其他类型眼眶炎症也可能受益于IGF-1R信号通路阻断。

研究设计与样本

  • 二次分析,对既往已报道的眶脂肪组织差异表达基因进行通路分析,样本经微阵列表征。
  • 组织标本来自10个国际中心(美国、加拿大、澳大利亚、沙特阿拉伯)的眼整形外科医生,诊断由两名设盲眼病理学家独立确认。
  • 基因表达谱分析在Oregon Health & Science University进行,共纳入83例参与者:25例TAO、6例眼眶GPA、7例眼眶sarcoidosis、25例NSOI和20例健康对照。

主要发现

  • 83例受试者平均(SD)年龄52.8(18.3)岁,70%(n=58)为女性。
  • OID患者与健康对照相比,IGF-1R下游基因表达(MAPK/RAS/RAF/MEK/ERK和PI3K/Akt/mTOR通路)、PPARγ、脂肪细胞因子和AMPK信号通路存在扰动。
  • GPA样本与对照在IGF-1R(PI3K-Akt p=0.001、RAS p=0.005)、PPARγ(p=0.002)、脂肪细胞因子(p=0.004)和AMPK(p<0.001)通路的基因表达存在差异。
  • TAO、sarcoidosis和NSOI样本在这些通路中也发现统计学显著的差异基因表达。

临床怎么用

  • 对于TAO以外的眼眶炎性疾病(如GPA、sarcoidosis、NSOI),可考虑IGF-1R信号通路作为潜在治疗靶点。
  • 通路分析结果支持在眼眶炎性疾病中进行共享信号通路的进一步机制研究和靶向治疗探索。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Orbital inflammatory disease (OID) encompasses a wide range of pathology including thyroid-associated orbitopathy (TAO), granulomatosis with polyangiitis (GPA), sarcoidosis and non-specific orbital inflammation (NSOI), accounting for up to 6% of orbital diseases. Understanding the underlying pathophysiology of OID can improve diagnosis and help target therapy. AIMS: To test the hypothesis that shared signalling pathways are activated in different forms of OID. METHODS: In this secondary analysis, pathway analysis was performed on the previously reported differentially expressed genes from orbital adipose tissue using patients with OID and healthy controls who were characterised by microarray. For the original publications, tissue specimens were collected from oculoplastic surgeons at 10 international centres representing four countries (USA, Canada, Australia and Saudi Arabia). Diagnoses were independently confirmed by two masked ocular pathologists (DJW, HEG). Gene expression profiling analysis was performed at the Oregon Health & Science University. Eighty-three participants were included: 25 with TAO, 6 with orbital GPA, 7 with orbital sarcoidosis, 25 with NSOI and 20 healthy controls. RESULTS: Among the 83 subjects (mean (SD) age, 52.8 (18.3) years; 70% (n=58) female), those with OID demonstrated perturbation of the downstream gene expressions of the IGF-1R (MAPK/RAS/RAF/MEK/ERK and PI3K/Akt/mTOR pathways), peroxisome proliferator-activated receptor-γ (PPARγ), adipocytokine and AMPK signalling pathways compared with healthy controls. Specifically, GPA samples differed from controls in gene expression within the insulin-like growth factor-1 receptor (IGF-1R, PI3K-Akt (p=0.001), RAS (p=0.005)), PPARγ (p=0.002), adipocytokine (p=0.004) or AMPK (p=<0.001) pathways. TAO, sarcoidosis and NSOI samples were also found to have statistically significant differential gene expression in these pathways. CONCLUSIONS: Although OID includes a heterogenous group of pathologies, TAO, GPA, sarcoidosis and NSOI share enrichment of common gene signalling pathways, namely IGF-1R, PPARγ, adipocytokine and AMPK. Pathway analyses of gene expression suggest that other forms of orbital inflammation in addition to TAO may benefit from blockade of IGF-1R signalling pathways.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Verma R, Choi D, Chen AJ, et al. Enrichment of IGF-1R and PPARγ signalling pathways in orbital inflammatory diseases: steps toward understanding pathogenesis. Br J Ophthalmol. 2021. PMID: 33637620. doi:10.1136/bjophthalmol-2020-318330

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。